nodes	percent_of_prediction	percent_of_DWPC	metapath
Pancuronium—SLC22A1—hematologic cancer	0.376	1	CbGaD
Pancuronium—SLC22A2—Daunorubicin—hematologic cancer	0.0568	0.125	CbGbCtD
Pancuronium—SLC22A2—Cytarabine—hematologic cancer	0.0501	0.11	CbGbCtD
Pancuronium—SLC22A2—Cladribine—hematologic cancer	0.0473	0.104	CbGbCtD
Pancuronium—SLC22A1—Cytarabine—hematologic cancer	0.0435	0.0955	CbGbCtD
Pancuronium—SLC22A2—Imatinib—hematologic cancer	0.0435	0.0955	CbGbCtD
Pancuronium—SLC22A1—Cladribine—hematologic cancer	0.0411	0.0902	CbGbCtD
Pancuronium—SLC22A1—Imatinib—hematologic cancer	0.0378	0.0829	CbGbCtD
Pancuronium—BCHE—Triamcinolone—hematologic cancer	0.0376	0.0825	CbGbCtD
Pancuronium—BCHE—Irinotecan—hematologic cancer	0.0285	0.0625	CbGbCtD
Pancuronium—SLC22A2—Vinblastine—hematologic cancer	0.0242	0.053	CbGbCtD
Pancuronium—BCHE—Cisplatin—hematologic cancer	0.0232	0.051	CbGbCtD
Pancuronium—SLC22A2—Cisplatin—hematologic cancer	0.0222	0.0486	CbGbCtD
Pancuronium—Vecuronium—SLC22A1—hematologic cancer	0.00149	0.458	CrCbGaD
Pancuronium—Rocuronium—SLC22A1—hematologic cancer	0.00133	0.408	CrCbGaD
Pancuronium—Vecuronium—ABCB1—hematologic cancer	0.000433	0.133	CrCbGaD
Pancuronium—Anaphylactoid reaction—Etoposide—hematologic cancer	0.000361	0.00299	CcSEcCtD
Pancuronium—Paralysis—Doxorubicin—hematologic cancer	0.000359	0.00298	CcSEcCtD
Pancuronium—Tachycardia—Busulfan—hematologic cancer	0.000357	0.00296	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Prednisolone—hematologic cancer	0.000356	0.00295	CcSEcCtD
Pancuronium—Bronchospasm—Gemcitabine—hematologic cancer	0.000348	0.00288	CcSEcCtD
Pancuronium—Anaphylactic shock—Fludarabine—hematologic cancer	0.000347	0.00288	CcSEcCtD
Pancuronium—Tachycardia—Procarbazine—hematologic cancer	0.000346	0.00287	CcSEcCtD
Pancuronium—Hypotension—Busulfan—hematologic cancer	0.000342	0.00283	CcSEcCtD
Pancuronium—Erythema—Lenalidomide—hematologic cancer	0.000341	0.00283	CcSEcCtD
Pancuronium—Apnoea—Methotrexate—hematologic cancer	0.00034	0.00282	CcSEcCtD
Pancuronium—Tachycardia—Bexarotene—hematologic cancer	0.00034	0.00281	CcSEcCtD
Pancuronium—Tachycardia—Dasatinib—hematologic cancer	0.00034	0.00281	CcSEcCtD
Pancuronium—Rash—Mechlorethamine—hematologic cancer	0.000338	0.0028	CcSEcCtD
Pancuronium—Dermatitis—Mechlorethamine—hematologic cancer	0.000337	0.0028	CcSEcCtD
Pancuronium—Erythema—Hydroxyurea—hematologic cancer	0.000337	0.00279	CcSEcCtD
Pancuronium—Flushing—Bortezomib—hematologic cancer	0.000335	0.00278	CcSEcCtD
Pancuronium—Flushing—Bleomycin—hematologic cancer	0.000332	0.00275	CcSEcCtD
Pancuronium—Hypotension—Procarbazine—hematologic cancer	0.000332	0.00275	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Triamcinolone—hematologic cancer	0.000327	0.00271	CcSEcCtD
Pancuronium—Flushing—Vinorelbine—hematologic cancer	0.000327	0.00271	CcSEcCtD
Pancuronium—Hypotension—Dasatinib—hematologic cancer	0.000325	0.00269	CcSEcCtD
Pancuronium—Hypersensitivity—Methoxsalen—hematologic cancer	0.000325	0.00269	CcSEcCtD
Pancuronium—Anaphylactic shock—Imatinib—hematologic cancer	0.00032	0.00265	CcSEcCtD
Pancuronium—Hypersensitivity—Mercaptopurine—hematologic cancer	0.000316	0.00262	CcSEcCtD
Pancuronium—Erythema—Bortezomib—hematologic cancer	0.000314	0.0026	CcSEcCtD
Pancuronium—Tachycardia—Nilotinib—hematologic cancer	0.000314	0.0026	CcSEcCtD
Pancuronium—Tachycardia—Imatinib—hematologic cancer	0.000312	0.00259	CcSEcCtD
Pancuronium—Erythema—Bleomycin—hematologic cancer	0.000312	0.00258	CcSEcCtD
Pancuronium—Hypersensitivity—Clofarabine—hematologic cancer	0.000311	0.00258	CcSEcCtD
Pancuronium—Hypersensitivity—Daunorubicin—hematologic cancer	0.000311	0.00258	CcSEcCtD
Pancuronium—Hypersensitivity—Pentostatin—hematologic cancer	0.00031	0.00257	CcSEcCtD
Pancuronium—Erythema—Vinorelbine—hematologic cancer	0.000307	0.00254	CcSEcCtD
Pancuronium—Tachycardia—Cladribine—hematologic cancer	0.000307	0.00254	CcSEcCtD
Pancuronium—Muscular weakness—Prednisolone—hematologic cancer	0.000304	0.00252	CcSEcCtD
Pancuronium—Hypotension—Nilotinib—hematologic cancer	0.0003	0.00249	CcSEcCtD
Pancuronium—Hypersensitivity—Idarubicin—hematologic cancer	0.000299	0.00248	CcSEcCtD
Pancuronium—Hypotension—Imatinib—hematologic cancer	0.000299	0.00248	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Dexamethasone—hematologic cancer	0.000297	0.00246	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Betamethasone—hematologic cancer	0.000297	0.00246	CcSEcCtD
Pancuronium—Bronchospasm—Etoposide—hematologic cancer	0.000297	0.00246	CcSEcCtD
Pancuronium—Respiratory failure—Methotrexate—hematologic cancer	0.000294	0.00243	CcSEcCtD
Pancuronium—Hypotension—Cladribine—hematologic cancer	0.000294	0.00243	CcSEcCtD
Pancuronium—Erythema—Thiotepa—hematologic cancer	0.000293	0.00243	CcSEcCtD
Pancuronium—Hypersensitivity—Teniposide—hematologic cancer	0.000291	0.00241	CcSEcCtD
Pancuronium—Flushing—Carmustine—hematologic cancer	0.00029	0.0024	CcSEcCtD
Pancuronium—Flushing—Alitretinoin—hematologic cancer	0.000287	0.00238	CcSEcCtD
Pancuronium—Anaphylactic shock—Melphalan—hematologic cancer	0.000287	0.00237	CcSEcCtD
Pancuronium—Flushing—Ifosfamide—hematologic cancer	0.000284	0.00235	CcSEcCtD
Pancuronium—Tachycardia—Melphalan—hematologic cancer	0.00028	0.00232	CcSEcCtD
Pancuronium—Muscular weakness—Triamcinolone—hematologic cancer	0.00028	0.00232	CcSEcCtD
Pancuronium—Rash—Methoxsalen—hematologic cancer	0.000278	0.00231	CcSEcCtD
Pancuronium—Dermatitis—Methoxsalen—hematologic cancer	0.000278	0.0023	CcSEcCtD
Pancuronium—Erythema—Carmustine—hematologic cancer	0.000272	0.00226	CcSEcCtD
Pancuronium—Tachycardia—Lenalidomide—hematologic cancer	0.000272	0.00225	CcSEcCtD
Pancuronium—Rash—Mercaptopurine—hematologic cancer	0.00027	0.00224	CcSEcCtD
Pancuronium—Dermatitis—Mercaptopurine—hematologic cancer	0.00027	0.00224	CcSEcCtD
Pancuronium—Flushing—Irinotecan—hematologic cancer	0.00027	0.00224	CcSEcCtD
Pancuronium—Hypersensitivity—Busulfan—hematologic cancer	0.00027	0.00223	CcSEcCtD
Pancuronium—Erythema—Alitretinoin—hematologic cancer	0.00027	0.00223	CcSEcCtD
Pancuronium—Hypotension—Melphalan—hematologic cancer	0.000268	0.00222	CcSEcCtD
Pancuronium—Rash—Daunorubicin—hematologic cancer	0.000267	0.00221	CcSEcCtD
Pancuronium—Rash—Clofarabine—hematologic cancer	0.000267	0.00221	CcSEcCtD
Pancuronium—Erythema—Ifosfamide—hematologic cancer	0.000266	0.00221	CcSEcCtD
Pancuronium—Dermatitis—Clofarabine—hematologic cancer	0.000266	0.00221	CcSEcCtD
Pancuronium—Dermatitis—Daunorubicin—hematologic cancer	0.000266	0.00221	CcSEcCtD
Pancuronium—Rash—Pentostatin—hematologic cancer	0.000265	0.0022	CcSEcCtD
Pancuronium—Rash—Anagrelide—hematologic cancer	0.000265	0.0022	CcSEcCtD
Pancuronium—Dermatitis—Pentostatin—hematologic cancer	0.000265	0.0022	CcSEcCtD
Pancuronium—Dermatitis—Anagrelide—hematologic cancer	0.000265	0.0022	CcSEcCtD
Pancuronium—Salivary hypersecretion—Epirubicin—hematologic cancer	0.000262	0.00217	CcSEcCtD
Pancuronium—Hypersensitivity—Procarbazine—hematologic cancer	0.000262	0.00217	CcSEcCtD
Pancuronium—Hypotension—Lenalidomide—hematologic cancer	0.00026	0.00216	CcSEcCtD
Pancuronium—Anaphylactic shock—Bortezomib—hematologic cancer	0.000256	0.00212	CcSEcCtD
Pancuronium—Hypersensitivity—Dasatinib—hematologic cancer	0.000256	0.00212	CcSEcCtD
Pancuronium—Hypersensitivity—Bexarotene—hematologic cancer	0.000256	0.00212	CcSEcCtD
Pancuronium—Rash—Idarubicin—hematologic cancer	0.000256	0.00212	CcSEcCtD
Pancuronium—Dermatitis—Idarubicin—hematologic cancer	0.000256	0.00212	CcSEcCtD
Pancuronium—Hypersensitivity—Fludarabine—hematologic cancer	0.000256	0.00212	CcSEcCtD
Pancuronium—Anaphylactic shock—Bleomycin—hematologic cancer	0.000254	0.00211	CcSEcCtD
Pancuronium—Muscular weakness—Dexamethasone—hematologic cancer	0.000254	0.0021	CcSEcCtD
Pancuronium—Muscular weakness—Betamethasone—hematologic cancer	0.000254	0.0021	CcSEcCtD
Pancuronium—Erythema—Mitoxantrone—hematologic cancer	0.000253	0.0021	CcSEcCtD
Pancuronium—Anaphylactic shock—Vinorelbine—hematologic cancer	0.00025	0.00207	CcSEcCtD
Pancuronium—Tachycardia—Bortezomib—hematologic cancer	0.00025	0.00207	CcSEcCtD
Pancuronium—Rash—Teniposide—hematologic cancer	0.000249	0.00206	CcSEcCtD
Pancuronium—Dermatitis—Teniposide—hematologic cancer	0.000249	0.00206	CcSEcCtD
Pancuronium—Erythema—Gemcitabine—hematologic cancer	0.000246	0.00204	CcSEcCtD
Pancuronium—Flushing—Cisplatin—hematologic cancer	0.000245	0.00203	CcSEcCtD
Pancuronium—Tachycardia—Vinorelbine—hematologic cancer	0.000244	0.00202	CcSEcCtD
Pancuronium—Salivary hypersecretion—Doxorubicin—hematologic cancer	0.000242	0.00201	CcSEcCtD
Pancuronium—Hypersensitivity—Chlorambucil—hematologic cancer	0.000242	0.00201	CcSEcCtD
Pancuronium—Hypotension—Bortezomib—hematologic cancer	0.00024	0.00199	CcSEcCtD
Pancuronium—Hypotension—Bleomycin—hematologic cancer	0.000238	0.00197	CcSEcCtD
Pancuronium—Hypersensitivity—Nilotinib—hematologic cancer	0.000237	0.00196	CcSEcCtD
Pancuronium—Hypersensitivity—Imatinib—hematologic cancer	0.000236	0.00195	CcSEcCtD
Pancuronium—Hypotension—Vinorelbine—hematologic cancer	0.000234	0.00194	CcSEcCtD
Pancuronium—Tachycardia—Thiotepa—hematologic cancer	0.000233	0.00193	CcSEcCtD
Pancuronium—Hypersensitivity—Cladribine—hematologic cancer	0.000231	0.00192	CcSEcCtD
Pancuronium—Rash—Busulfan—hematologic cancer	0.000231	0.00191	CcSEcCtD
Pancuronium—Dermatitis—Busulfan—hematologic cancer	0.00023	0.00191	CcSEcCtD
Pancuronium—Erythema—Cisplatin—hematologic cancer	0.00023	0.0019	CcSEcCtD
Pancuronium—Tachycardia—Thalidomide—hematologic cancer	0.000226	0.00187	CcSEcCtD
Pancuronium—Flushing—Etoposide—hematologic cancer	0.000224	0.00186	CcSEcCtD
Pancuronium—Rash—Procarbazine—hematologic cancer	0.000224	0.00185	CcSEcCtD
Pancuronium—Dermatitis—Procarbazine—hematologic cancer	0.000224	0.00185	CcSEcCtD
Pancuronium—Hypersensitivity—Vinblastine—hematologic cancer	0.000222	0.00184	CcSEcCtD
Pancuronium—Muscular weakness—Prednisone—hematologic cancer	0.000221	0.00183	CcSEcCtD
Pancuronium—Anaphylactic shock—Alitretinoin—hematologic cancer	0.00022	0.00182	CcSEcCtD
Pancuronium—Rash—Dasatinib—hematologic cancer	0.000219	0.00182	CcSEcCtD
Pancuronium—Rash—Bexarotene—hematologic cancer	0.000219	0.00182	CcSEcCtD
Pancuronium—Dermatitis—Bexarotene—hematologic cancer	0.000219	0.00182	CcSEcCtD
Pancuronium—Dermatitis—Dasatinib—hematologic cancer	0.000219	0.00182	CcSEcCtD
Pancuronium—Rash—Fludarabine—hematologic cancer	0.000219	0.00181	CcSEcCtD
Pancuronium—Dermatitis—Fludarabine—hematologic cancer	0.000219	0.00181	CcSEcCtD
Pancuronium—Anaphylactic shock—Ifosfamide—hematologic cancer	0.000217	0.0018	CcSEcCtD
Pancuronium—Tachycardia—Carmustine—hematologic cancer	0.000217	0.0018	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Methotrexate—hematologic cancer	0.000216	0.00179	CcSEcCtD
Pancuronium—Hypotension—Thalidomide—hematologic cancer	0.000216	0.00179	CcSEcCtD
Pancuronium—Tachycardia—Alitretinoin—hematologic cancer	0.000215	0.00178	CcSEcCtD
Pancuronium—Anaphylactic shock—Vincristine—hematologic cancer	0.000212	0.00176	CcSEcCtD
Pancuronium—Hypersensitivity—Melphalan—hematologic cancer	0.000211	0.00175	CcSEcCtD
Pancuronium—Erythema—Prednisolone—hematologic cancer	0.000208	0.00172	CcSEcCtD
Pancuronium—Hypotension—Carmustine—hematologic cancer	0.000208	0.00172	CcSEcCtD
Pancuronium—Anaphylactic shock—Irinotecan—hematologic cancer	0.000206	0.00171	CcSEcCtD
Pancuronium—Anaphylactic shock—Mitoxantrone—hematologic cancer	0.000206	0.00171	CcSEcCtD
Pancuronium—Hypotension—Alitretinoin—hematologic cancer	0.000206	0.0017	CcSEcCtD
Pancuronium—Hypersensitivity—Lenalidomide—hematologic cancer	0.000205	0.0017	CcSEcCtD
Pancuronium—Hypotension—Ifosfamide—hematologic cancer	0.000203	0.00168	CcSEcCtD
Pancuronium—Rash—Nilotinib—hematologic cancer	0.000203	0.00168	CcSEcCtD
Pancuronium—Dermatitis—Nilotinib—hematologic cancer	0.000203	0.00168	CcSEcCtD
Pancuronium—Hypersensitivity—Hydroxyurea—hematologic cancer	0.000202	0.00168	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Epirubicin—hematologic cancer	0.000202	0.00168	CcSEcCtD
Pancuronium—Rash—Imatinib—hematologic cancer	0.000202	0.00167	CcSEcCtD
Pancuronium—Tachycardia—Mitoxantrone—hematologic cancer	0.000202	0.00167	CcSEcCtD
Pancuronium—Dermatitis—Imatinib—hematologic cancer	0.000201	0.00167	CcSEcCtD
Pancuronium—Anaphylactic shock—Gemcitabine—hematologic cancer	0.000201	0.00167	CcSEcCtD
Pancuronium—Hypotension—Vincristine—hematologic cancer	0.000198	0.00164	CcSEcCtD
Pancuronium—Rash—Cladribine—hematologic cancer	0.000198	0.00164	CcSEcCtD
Pancuronium—Dermatitis—Cladribine—hematologic cancer	0.000198	0.00164	CcSEcCtD
Pancuronium—Hypotension—Mitoxantrone—hematologic cancer	0.000193	0.0016	CcSEcCtD
Pancuronium—Hypotension—Irinotecan—hematologic cancer	0.000193	0.0016	CcSEcCtD
Pancuronium—Erythema—Triamcinolone—hematologic cancer	0.000191	0.00158	CcSEcCtD
Pancuronium—Hypersensitivity—Bortezomib—hematologic cancer	0.000189	0.00157	CcSEcCtD
Pancuronium—Hypotension—Gemcitabine—hematologic cancer	0.000188	0.00156	CcSEcCtD
Pancuronium—Anaphylactic shock—Cisplatin—hematologic cancer	0.000187	0.00155	CcSEcCtD
Pancuronium—Hypersensitivity—Bleomycin—hematologic cancer	0.000187	0.00155	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Doxorubicin—hematologic cancer	0.000187	0.00155	CcSEcCtD
Pancuronium—Hypersensitivity—Vinorelbine—hematologic cancer	0.000184	0.00153	CcSEcCtD
Pancuronium—Tachycardia—Cisplatin—hematologic cancer	0.000183	0.00152	CcSEcCtD
Pancuronium—Rash—Melphalan—hematologic cancer	0.000181	0.0015	CcSEcCtD
Pancuronium—Dermatitis—Melphalan—hematologic cancer	0.000181	0.0015	CcSEcCtD
Pancuronium—Hypersensitivity—Thiotepa—hematologic cancer	0.000176	0.00146	CcSEcCtD
Pancuronium—Rash—Lenalidomide—hematologic cancer	0.000176	0.00146	CcSEcCtD
Pancuronium—Dermatitis—Lenalidomide—hematologic cancer	0.000176	0.00145	CcSEcCtD
Pancuronium—Hypotension—Cisplatin—hematologic cancer	0.000175	0.00145	CcSEcCtD
Pancuronium—Rash—Hydroxyurea—hematologic cancer	0.000173	0.00144	CcSEcCtD
Pancuronium—Erythema—Dexamethasone—hematologic cancer	0.000173	0.00144	CcSEcCtD
Pancuronium—Erythema—Betamethasone—hematologic cancer	0.000173	0.00144	CcSEcCtD
Pancuronium—Dermatitis—Hydroxyurea—hematologic cancer	0.000173	0.00143	CcSEcCtD
Pancuronium—Muscular weakness—Epirubicin—hematologic cancer	0.000173	0.00143	CcSEcCtD
Pancuronium—Anaphylactic shock—Etoposide—hematologic cancer	0.000172	0.00142	CcSEcCtD
Pancuronium—Hypersensitivity—Thalidomide—hematologic cancer	0.00017	0.00141	CcSEcCtD
Pancuronium—Anaphylactic shock—Prednisolone—hematologic cancer	0.000169	0.0014	CcSEcCtD
Pancuronium—Tachycardia—Etoposide—hematologic cancer	0.000168	0.00139	CcSEcCtD
Pancuronium—Tachycardia—Prednisolone—hematologic cancer	0.000165	0.00137	CcSEcCtD
Pancuronium—Hypersensitivity—Carmustine—hematologic cancer	0.000164	0.00136	CcSEcCtD
Pancuronium—Hypersensitivity—Alitretinoin—hematologic cancer	0.000162	0.00134	CcSEcCtD
Pancuronium—Rash—Bortezomib—hematologic cancer	0.000162	0.00134	CcSEcCtD
Pancuronium—Dermatitis—Bortezomib—hematologic cancer	0.000162	0.00134	CcSEcCtD
Pancuronium—Flushing—Prednisone—hematologic cancer	0.000161	0.00133	CcSEcCtD
Pancuronium—CHRNA1—hematopoietic system—hematologic cancer	0.000161	0.189	CbGeAlD
Pancuronium—Hypotension—Etoposide—hematologic cancer	0.00016	0.00133	CcSEcCtD
Pancuronium—Rash—Bleomycin—hematologic cancer	0.00016	0.00133	CcSEcCtD
Pancuronium—Dermatitis—Bleomycin—hematologic cancer	0.00016	0.00133	CcSEcCtD
Pancuronium—Hypersensitivity—Ifosfamide—hematologic cancer	0.00016	0.00133	CcSEcCtD
Pancuronium—Muscular weakness—Doxorubicin—hematologic cancer	0.00016	0.00132	CcSEcCtD
Pancuronium—Rash—Vinorelbine—hematologic cancer	0.000158	0.00131	CcSEcCtD
Pancuronium—Dermatitis—Vinorelbine—hematologic cancer	0.000158	0.00131	CcSEcCtD
Pancuronium—Hypersensitivity—Vincristine—hematologic cancer	0.000156	0.00129	CcSEcCtD
Pancuronium—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000156	0.00129	CcSEcCtD
Pancuronium—Hypersensitivity—Irinotecan—hematologic cancer	0.000152	0.00126	CcSEcCtD
Pancuronium—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000152	0.00126	CcSEcCtD
Pancuronium—Tachycardia—Triamcinolone—hematologic cancer	0.000152	0.00126	CcSEcCtD
Pancuronium—Erythema—Prednisone—hematologic cancer	0.000151	0.00125	CcSEcCtD
Pancuronium—Rash—Thiotepa—hematologic cancer	0.000151	0.00125	CcSEcCtD
Pancuronium—Dermatitis—Thiotepa—hematologic cancer	0.000151	0.00125	CcSEcCtD
Pancuronium—Rash—Thalidomide—hematologic cancer	0.000146	0.00121	CcSEcCtD
Pancuronium—Dermatitis—Thalidomide—hematologic cancer	0.000146	0.00121	CcSEcCtD
Pancuronium—Anaphylactic shock—Betamethasone—hematologic cancer	0.000141	0.00117	CcSEcCtD
Pancuronium—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000141	0.00117	CcSEcCtD
Pancuronium—Rash—Carmustine—hematologic cancer	0.00014	0.00116	CcSEcCtD
Pancuronium—Dermatitis—Carmustine—hematologic cancer	0.00014	0.00116	CcSEcCtD
Pancuronium—Rash—Alitretinoin—hematologic cancer	0.000139	0.00115	CcSEcCtD
Pancuronium—Dermatitis—Alitretinoin—hematologic cancer	0.000139	0.00115	CcSEcCtD
Pancuronium—Hypersensitivity—Cisplatin—hematologic cancer	0.000138	0.00114	CcSEcCtD
Pancuronium—Tachycardia—Dexamethasone—hematologic cancer	0.000138	0.00114	CcSEcCtD
Pancuronium—Tachycardia—Betamethasone—hematologic cancer	0.000138	0.00114	CcSEcCtD
Pancuronium—Rash—Ifosfamide—hematologic cancer	0.000137	0.00114	CcSEcCtD
Pancuronium—Dermatitis—Ifosfamide—hematologic cancer	0.000137	0.00114	CcSEcCtD
Pancuronium—Rash—Vincristine—hematologic cancer	0.000134	0.00111	CcSEcCtD
Pancuronium—Dermatitis—Vincristine—hematologic cancer	0.000134	0.00111	CcSEcCtD
Pancuronium—Hypotension—Betamethasone—hematologic cancer	0.000132	0.00109	CcSEcCtD
Pancuronium—Hypotension—Dexamethasone—hematologic cancer	0.000132	0.00109	CcSEcCtD
Pancuronium—Rash—Mitoxantrone—hematologic cancer	0.00013	0.00108	CcSEcCtD
Pancuronium—Rash—Irinotecan—hematologic cancer	0.00013	0.00108	CcSEcCtD
Pancuronium—Dermatitis—Irinotecan—hematologic cancer	0.00013	0.00108	CcSEcCtD
Pancuronium—Dermatitis—Mitoxantrone—hematologic cancer	0.00013	0.00108	CcSEcCtD
Pancuronium—Rash—Gemcitabine—hematologic cancer	0.000127	0.00105	CcSEcCtD
Pancuronium—Dermatitis—Gemcitabine—hematologic cancer	0.000127	0.00105	CcSEcCtD
Pancuronium—Hypersensitivity—Etoposide—hematologic cancer	0.000127	0.00105	CcSEcCtD
Pancuronium—Erythema—Methotrexate—hematologic cancer	0.000126	0.00104	CcSEcCtD
Pancuronium—Flushing—Epirubicin—hematologic cancer	0.000126	0.00104	CcSEcCtD
Pancuronium—Hypersensitivity—Prednisolone—hematologic cancer	0.000125	0.00103	CcSEcCtD
Pancuronium—Anaphylactic shock—Prednisone—hematologic cancer	0.000123	0.00102	CcSEcCtD
Pancuronium—Tachycardia—Prednisone—hematologic cancer	0.00012	0.000996	CcSEcCtD
Pancuronium—Rash—Cisplatin—hematologic cancer	0.000118	0.00098	CcSEcCtD
Pancuronium—Dermatitis—Cisplatin—hematologic cancer	0.000118	0.000979	CcSEcCtD
Pancuronium—Erythema—Epirubicin—hematologic cancer	0.000118	0.000978	CcSEcCtD
Pancuronium—Flushing—Doxorubicin—hematologic cancer	0.000116	0.000964	CcSEcCtD
Pancuronium—Hypersensitivity—Triamcinolone—hematologic cancer	0.000115	0.000951	CcSEcCtD
Pancuronium—CHRND—lung—hematologic cancer	0.000112	0.132	CbGeAlD
Pancuronium—Erythema—Doxorubicin—hematologic cancer	0.000109	0.000905	CcSEcCtD
Pancuronium—Rash—Etoposide—hematologic cancer	0.000108	0.000897	CcSEcCtD
Pancuronium—Dermatitis—Etoposide—hematologic cancer	0.000108	0.000897	CcSEcCtD
Pancuronium—Rash—Prednisolone—hematologic cancer	0.000107	0.000885	CcSEcCtD
Pancuronium—Dermatitis—Prednisolone—hematologic cancer	0.000107	0.000884	CcSEcCtD
Pancuronium—Anaphylactic shock—Methotrexate—hematologic cancer	0.000103	0.000853	CcSEcCtD
Pancuronium—Rash—Triamcinolone—hematologic cancer	9.82e-05	0.000814	CcSEcCtD
Pancuronium—Dermatitis—Triamcinolone—hematologic cancer	9.81e-05	0.000813	CcSEcCtD
Pancuronium—Anaphylactic shock—Epirubicin—hematologic cancer	9.63e-05	0.000798	CcSEcCtD
Pancuronium—Hypotension—Methotrexate—hematologic cancer	9.61e-05	0.000797	CcSEcCtD
Pancuronium—Tachycardia—Epirubicin—hematologic cancer	9.4e-05	0.000779	CcSEcCtD
Pancuronium—Hypersensitivity—Prednisone—hematologic cancer	9.07e-05	0.000752	CcSEcCtD
Pancuronium—Hypotension—Epirubicin—hematologic cancer	9e-05	0.000746	CcSEcCtD
Pancuronium—Rash—Dexamethasone—hematologic cancer	8.91e-05	0.000739	CcSEcCtD
Pancuronium—Rash—Betamethasone—hematologic cancer	8.91e-05	0.000739	CcSEcCtD
Pancuronium—Anaphylactic shock—Doxorubicin—hematologic cancer	8.91e-05	0.000738	CcSEcCtD
Pancuronium—Dermatitis—Betamethasone—hematologic cancer	8.9e-05	0.000738	CcSEcCtD
Pancuronium—Dermatitis—Dexamethasone—hematologic cancer	8.9e-05	0.000738	CcSEcCtD
Pancuronium—CHRNA2—blood—hematologic cancer	8.83e-05	0.104	CbGeAlD
Pancuronium—Tachycardia—Doxorubicin—hematologic cancer	8.69e-05	0.00072	CcSEcCtD
Pancuronium—Hypotension—Doxorubicin—hematologic cancer	8.32e-05	0.00069	CcSEcCtD
Pancuronium—CHRNB1—blood—hematologic cancer	8.21e-05	0.0967	CbGeAlD
Pancuronium—Rash—Prednisone—hematologic cancer	7.76e-05	0.000643	CcSEcCtD
Pancuronium—Dermatitis—Prednisone—hematologic cancer	7.75e-05	0.000643	CcSEcCtD
Pancuronium—Hypersensitivity—Methotrexate—hematologic cancer	7.58e-05	0.000628	CcSEcCtD
Pancuronium—Hypersensitivity—Epirubicin—hematologic cancer	7.09e-05	0.000588	CcSEcCtD
Pancuronium—CHRNB1—testis—hematologic cancer	6.79e-05	0.08	CbGeAlD
Pancuronium—Hypersensitivity—Doxorubicin—hematologic cancer	6.56e-05	0.000544	CcSEcCtD
Pancuronium—Rash—Methotrexate—hematologic cancer	6.49e-05	0.000538	CcSEcCtD
Pancuronium—Dermatitis—Methotrexate—hematologic cancer	6.48e-05	0.000537	CcSEcCtD
Pancuronium—Rash—Epirubicin—hematologic cancer	6.07e-05	0.000503	CcSEcCtD
Pancuronium—Dermatitis—Epirubicin—hematologic cancer	6.06e-05	0.000503	CcSEcCtD
Pancuronium—Rash—Doxorubicin—hematologic cancer	5.62e-05	0.000465	CcSEcCtD
Pancuronium—Dermatitis—Doxorubicin—hematologic cancer	5.61e-05	0.000465	CcSEcCtD
Pancuronium—BCHE—hematopoietic system—hematologic cancer	5.28e-05	0.0622	CbGeAlD
Pancuronium—SLC22A1—blood—hematologic cancer	5.17e-05	0.0609	CbGeAlD
Pancuronium—CHRNB1—lymph node—hematologic cancer	4.92e-05	0.058	CbGeAlD
Pancuronium—CHRM3—testis—hematologic cancer	3.55e-05	0.0417	CbGeAlD
Pancuronium—BCHE—blood—hematologic cancer	3.5e-05	0.0412	CbGeAlD
Pancuronium—BCHE—bone marrow—hematologic cancer	3.39e-05	0.0399	CbGeAlD
Pancuronium—BCHE—lung—hematologic cancer	3.07e-05	0.0361	CbGeAlD
Pancuronium—BCHE—testis—hematologic cancer	2.89e-05	0.0341	CbGeAlD
Pancuronium—BCHE—lymph node—hematologic cancer	2.1e-05	0.0247	CbGeAlD
Pancuronium—SLC22A1—Metabolism—ABCB1—hematologic cancer	6.5e-06	0.00015	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—FBXW7—hematologic cancer	6.5e-06	0.00015	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HDAC2—hematologic cancer	6.43e-06	0.000149	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CXCR4—hematologic cancer	6.43e-06	0.000149	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HDAC2—hematologic cancer	6.37e-06	0.000147	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CXCR4—hematologic cancer	6.37e-06	0.000147	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—GSTP1—hematologic cancer	6.35e-06	0.000147	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—GSTM1—hematologic cancer	6.31e-06	0.000146	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—NCOR1—hematologic cancer	6.31e-06	0.000146	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CBL—hematologic cancer	6.27e-06	0.000145	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CBL—hematologic cancer	6.21e-06	0.000143	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IL3—hematologic cancer	6.2e-06	0.000143	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IL3—hematologic cancer	6.14e-06	0.000142	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PIK3CG—hematologic cancer	6.13e-06	0.000142	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PTPN1—hematologic cancer	6.1e-06	0.000141	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PIK3CG—hematologic cancer	6.07e-06	0.00014	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PTPN1—hematologic cancer	6.04e-06	0.000139	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PTPN11—hematologic cancer	6.02e-06	0.000139	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ABCB1—hematologic cancer	6.01e-06	0.000139	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—RASGRP1—hematologic cancer	6e-06	0.000139	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—MTHFR—hematologic cancer	5.99e-06	0.000138	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HSP90AA1—hematologic cancer	5.98e-06	0.000138	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—SYK—hematologic cancer	5.98e-06	0.000138	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PTPN11—hematologic cancer	5.96e-06	0.000138	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—RASGRP1—hematologic cancer	5.94e-06	0.000137	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—PIK3CD—hematologic cancer	5.93e-06	0.000137	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HSP90AA1—hematologic cancer	5.92e-06	0.000137	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—SYK—hematologic cancer	5.92e-06	0.000137	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.91e-06	0.000136	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—PIK3CD—hematologic cancer	5.88e-06	0.000136	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—CREB1—hematologic cancer	5.83e-06	0.000135	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—NCOR1—hematologic cancer	5.83e-06	0.000135	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—GSTM1—hematologic cancer	5.83e-06	0.000135	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—CREB1—hematologic cancer	5.78e-06	0.000133	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—STAT1—hematologic cancer	5.77e-06	0.000133	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—STAT1—hematologic cancer	5.71e-06	0.000132	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—CCL2—hematologic cancer	5.71e-06	0.000132	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—IL6R—hematologic cancer	5.69e-06	0.000131	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—CCL2—hematologic cancer	5.65e-06	0.000131	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—IL6R—hematologic cancer	5.64e-06	0.00013	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PIK3CG—hematologic cancer	5.63e-06	0.00013	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—PIK3R1—hematologic cancer	5.6e-06	0.000129	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—MTHFR—hematologic cancer	5.58e-06	0.000129	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—PIK3R1—hematologic cancer	5.55e-06	0.000128	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—JAK2—hematologic cancer	5.44e-06	0.000126	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—MAP2K1—hematologic cancer	5.42e-06	0.000125	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—GRB2—hematologic cancer	5.4e-06	0.000125	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—JAK2—hematologic cancer	5.39e-06	0.000125	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PIK3CD—hematologic cancer	5.39e-06	0.000124	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PDGFA—hematologic cancer	5.38e-06	0.000124	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—MAP2K1—hematologic cancer	5.37e-06	0.000124	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—GRB2—hematologic cancer	5.34e-06	0.000123	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PIK3CD—hematologic cancer	5.34e-06	0.000123	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PDGFA—hematologic cancer	5.33e-06	0.000123	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—KITLG—hematologic cancer	5.31e-06	0.000123	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—KITLG—hematologic cancer	5.25e-06	0.000121	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—CREBBP—hematologic cancer	5.22e-06	0.000121	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—STAT5A—hematologic cancer	5.19e-06	0.00012	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—PIK3CB—hematologic cancer	5.17e-06	0.000119	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—MTHFR—hematologic cancer	5.15e-06	0.000119	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CDKN2B—hematologic cancer	5.14e-06	0.000119	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—STAT5A—hematologic cancer	5.14e-06	0.000119	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—PIK3CB—hematologic cancer	5.12e-06	0.000118	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CDKN2B—hematologic cancer	5.09e-06	0.000118	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PIK3R1—hematologic cancer	5.09e-06	0.000117	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PIK3R1—hematologic cancer	5.04e-06	0.000116	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PIK3CG—hematologic cancer	5.03e-06	0.000116	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CD86—hematologic cancer	4.97e-06	0.000115	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PIK3CD—hematologic cancer	4.95e-06	0.000114	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—JAK2—hematologic cancer	4.94e-06	0.000114	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CD86—hematologic cancer	4.92e-06	0.000114	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HES1—hematologic cancer	4.9e-06	0.000113	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—JAK2—hematologic cancer	4.9e-06	0.000113	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—ALB—hematologic cancer	4.89e-06	0.000113	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NCOR1—hematologic cancer	4.88e-06	0.000113	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HES1—hematologic cancer	4.86e-06	0.000112	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NCOR1—hematologic cancer	4.83e-06	0.000112	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—FGF1—hematologic cancer	4.82e-06	0.000111	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CSF2—hematologic cancer	4.82e-06	0.000111	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—FGF1—hematologic cancer	4.77e-06	0.00011	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CSF2—hematologic cancer	4.77e-06	0.00011	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—FOXO1—hematologic cancer	4.75e-06	0.00011	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—IL2—hematologic cancer	4.75e-06	0.00011	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PDGFRB—hematologic cancer	4.74e-06	0.00011	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—FOXO1—hematologic cancer	4.71e-06	0.000109	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—IL2—hematologic cancer	4.7e-06	0.000109	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PDGFRB—hematologic cancer	4.7e-06	0.000108	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PIK3CB—hematologic cancer	4.7e-06	0.000108	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PIK3CG—hematologic cancer	4.69e-06	0.000108	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PIK3R1—hematologic cancer	4.67e-06	0.000108	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PDGFRA—hematologic cancer	4.67e-06	0.000108	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—CREBBP—hematologic cancer	4.66e-06	0.000108	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PRKCG—hematologic cancer	4.65e-06	0.000107	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—JAK1—hematologic cancer	4.65e-06	0.000107	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PIK3CB—hematologic cancer	4.65e-06	0.000107	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PDGFRA—hematologic cancer	4.62e-06	0.000107	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—JAK1—hematologic cancer	4.61e-06	0.000106	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PRKCG—hematologic cancer	4.61e-06	0.000106	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PIK3CD—hematologic cancer	4.42e-06	0.000102	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—ALB—hematologic cancer	4.36e-06	0.000101	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—CREBBP—hematologic cancer	4.35e-06	0.0001	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IL2RA—hematologic cancer	4.35e-06	0.0001	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PIK3CG—hematologic cancer	4.33e-06	0.0001	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PIK3CB—hematologic cancer	4.31e-06	9.96e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—IL2—hematologic cancer	4.31e-06	9.96e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IL2RA—hematologic cancer	4.3e-06	9.94e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TERT—hematologic cancer	4.3e-06	9.92e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—IL2—hematologic cancer	4.27e-06	9.86e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TERT—hematologic cancer	4.26e-06	9.83e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PDGFB—hematologic cancer	4.19e-06	9.69e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PIK3R1—hematologic cancer	4.17e-06	9.64e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	4.15e-06	9.59e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PIK3CD—hematologic cancer	4.12e-06	9.52e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TSC2—hematologic cancer	4.1e-06	9.47e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ALB—hematologic cancer	4.07e-06	9.39e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TSC2—hematologic cancer	4.06e-06	9.37e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CREBBP—hematologic cancer	4.01e-06	9.27e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—FGFR3—hematologic cancer	3.94e-06	9.11e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	3.9e-06	9.02e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MAPK14—hematologic cancer	3.9e-06	9.02e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PIK3R1—hematologic cancer	3.89e-06	8.99e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	3.87e-06	8.93e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PIK3CB—hematologic cancer	3.85e-06	8.9e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ESR1—hematologic cancer	3.83e-06	8.84e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PIK3CD—hematologic cancer	3.81e-06	8.79e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ESR1—hematologic cancer	3.79e-06	8.76e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—FN1—hematologic cancer	3.78e-06	8.74e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ALB—hematologic cancer	3.76e-06	8.68e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—FN1—hematologic cancer	3.75e-06	8.65e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—BAD—hematologic cancer	3.74e-06	8.63e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NFKBIA—hematologic cancer	3.74e-06	8.63e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PTEN—hematologic cancer	3.73e-06	8.61e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NOTCH1—hematologic cancer	3.7e-06	8.55e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	3.7e-06	8.55e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—BAD—hematologic cancer	3.7e-06	8.55e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	3.67e-06	8.47e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CD80—hematologic cancer	3.63e-06	8.38e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—KIT—hematologic cancer	3.62e-06	8.36e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PIK3CG—hematologic cancer	3.62e-06	8.36e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—NRAS—hematologic cancer	3.62e-06	8.36e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PIK3R1—hematologic cancer	3.59e-06	8.3e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CD80—hematologic cancer	3.59e-06	8.29e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PIK3CB—hematologic cancer	3.59e-06	8.29e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—KIT—hematologic cancer	3.59e-06	8.28e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	3.59e-06	8.28e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	3.59e-06	8.28e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PTPN11—hematologic cancer	3.56e-06	8.21e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—EP300—hematologic cancer	3.56e-06	8.21e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	3.52e-06	8.13e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—MAPK3—hematologic cancer	3.47e-06	8.01e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CREB1—hematologic cancer	3.45e-06	7.96e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	3.43e-06	7.93e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CREB1—hematologic cancer	3.41e-06	7.88e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—BRAF—hematologic cancer	3.4e-06	7.86e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CCL2—hematologic cancer	3.37e-06	7.79e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—BRAF—hematologic cancer	3.37e-06	7.78e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IL6R—hematologic cancer	3.36e-06	7.76e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CREBBP—hematologic cancer	3.36e-06	7.75e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CCL2—hematologic cancer	3.34e-06	7.71e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PTEN—hematologic cancer	3.33e-06	7.69e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IL6R—hematologic cancer	3.33e-06	7.69e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	3.32e-06	7.68e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PIK3CB—hematologic cancer	3.32e-06	7.66e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MAP2K1—hematologic cancer	3.2e-06	7.4e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PIK3CD—hematologic cancer	3.18e-06	7.35e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—EP300—hematologic cancer	3.18e-06	7.33e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	3.17e-06	7.33e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—PIK3CA—hematologic cancer	3.15e-06	7.28e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	3.15e-06	7.28e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	3.12e-06	7.21e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—KRAS—hematologic cancer	3.12e-06	7.2e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PTEN—hematologic cancer	3.1e-06	7.17e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	3.09e-06	7.13e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—FGF2—hematologic cancer	3.05e-06	7.04e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—FGF2—hematologic cancer	3.02e-06	6.97e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PIK3R1—hematologic cancer	3.01e-06	6.94e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	2.98e-06	6.87e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—EP300—hematologic cancer	2.96e-06	6.83e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—JAK2—hematologic cancer	2.92e-06	6.75e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—JAK2—hematologic cancer	2.89e-06	6.68e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PTEN—hematologic cancer	2.87e-06	6.62e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PIK3CA—hematologic cancer	2.86e-06	6.61e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MDM2—hematologic cancer	2.85e-06	6.58e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	2.83e-06	6.55e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MDM2—hematologic cancer	2.82e-06	6.52e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MTOR—hematologic cancer	2.77e-06	6.41e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PIK3CB—hematologic cancer	2.77e-06	6.41e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MTOR—hematologic cancer	2.75e-06	6.34e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	2.75e-06	6.34e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—EP300—hematologic cancer	2.73e-06	6.31e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—HRAS—hematologic cancer	2.65e-06	6.12e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PIK3CA—hematologic cancer	2.63e-06	6.07e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	2.62e-06	6.06e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CDKN1B—hematologic cancer	2.6e-06	6.01e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	2.58e-06	5.95e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—AKT1—hematologic cancer	2.58e-06	5.95e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CASP3—hematologic cancer	2.55e-06	5.89e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	2.55e-06	5.89e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IL2—hematologic cancer	2.55e-06	5.88e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—IL6—hematologic cancer	2.53e-06	5.85e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CASP3—hematologic cancer	2.53e-06	5.84e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IL2—hematologic cancer	2.52e-06	5.83e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—IL6—hematologic cancer	2.51e-06	5.8e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CCND1—hematologic cancer	2.48e-06	5.74e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—JUN—hematologic cancer	2.48e-06	5.72e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CCND1—hematologic cancer	2.46e-06	5.68e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—JUN—hematologic cancer	2.45e-06	5.67e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CDKN1A—hematologic cancer	2.4e-06	5.55e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PTEN—hematologic cancer	2.4e-06	5.54e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	2.38e-06	5.49e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PTEN—hematologic cancer	2.37e-06	5.48e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PIK3CA—hematologic cancer	2.35e-06	5.42e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MAPK8—hematologic cancer	2.35e-06	5.42e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—AKT1—hematologic cancer	2.34e-06	5.4e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	2.32e-06	5.36e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	2.32e-06	5.35e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—EP300—hematologic cancer	2.29e-06	5.28e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—EP300—hematologic cancer	2.26e-06	5.23e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—SRC—hematologic cancer	2.22e-06	5.13e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—SRC—hematologic cancer	2.2e-06	5.08e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PIK3CA—hematologic cancer	2.19e-06	5.06e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	2.17e-06	5e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—AKT1—hematologic cancer	2.15e-06	4.96e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	2.14e-06	4.95e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—STAT3—hematologic cancer	2.14e-06	4.95e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NRAS—hematologic cancer	2.14e-06	4.94e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—STAT3—hematologic cancer	2.12e-06	4.9e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NRAS—hematologic cancer	2.12e-06	4.89e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	2.05e-06	4.73e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	2.03e-06	4.68e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PIK3CA—hematologic cancer	2.02e-06	4.67e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MYC—hematologic cancer	1.99e-06	4.6e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	1.99e-06	4.59e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MYC—hematologic cancer	1.97e-06	4.56e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	1.97e-06	4.54e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—AKT1—hematologic cancer	1.92e-06	4.43e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—KRAS—hematologic cancer	1.84e-06	4.25e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—KRAS—hematologic cancer	1.82e-06	4.21e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—AKT1—hematologic cancer	1.79e-06	4.13e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	1.69e-06	3.91e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	1.67e-06	3.87e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—AKT1—hematologic cancer	1.65e-06	3.82e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TP53—hematologic cancer	1.64e-06	3.78e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TP53—hematologic cancer	1.62e-06	3.74e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HRAS—hematologic cancer	1.56e-06	3.61e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HRAS—hematologic cancer	1.55e-06	3.58e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IL6—hematologic cancer	1.5e-06	3.46e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IL6—hematologic cancer	1.48e-06	3.42e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—AKT1—hematologic cancer	1.38e-06	3.19e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—AKT1—hematologic cancer	1.37e-06	3.16e-05	CbGpPWpGaD
